10x Genomics Inc (TXG)
14.04
+0.43
(+3.16%)
USD |
NASDAQ |
Dec 20, 16:00
14.06
+0.02
(+0.14%)
After-Hours: 20:00
10x Genomics Cash from Investing (Quarterly): -3.618M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Omnicell Inc | -13.34M |
| American Shared Hospital Services | -0.704M |
| Astrana Health Inc | -8.107M |
| Cryo-Cell International Inc | -0.6656M |
| P3 Health Partners Inc | 15.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 21.64M |
| Cash from Financing (Quarterly) | 0.156M |
| Free Cash Flow | 25.04M |
| Free Cash Flow Per Share (Quarterly) | 0.147 |
| Free Cash Flow to Equity (Quarterly) | 17.75M |
| Free Cash Flow to Firm (Quarterly) | 17.75M |
| Free Cash Flow Yield | 1.49% |